- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: IBI311
Total 359 results
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruitingNeovascular Age-related Macular DegenerationChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedDiabetic Macular EdemaChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedNon-Squamous Non-Small Cell Lung CancerChina
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingUlcerative Colitis (UC)China
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedIndolent Non-hodgkin LymphomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Terminated
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruitingAdvanced Hepatocellular CarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedHypercholesterolemiaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Completed
-
Innovent Biologics (Suzhou) Co. Ltd.Active, not recruitingOverweight/ ObesityChina
-
Shanghai Ninth People's Hospital Affiliated to...UnknownPrecancerous Conditions | Oral Cavity Cancer | Mouth NeoplasmChina
-
Innovent Biologics (Suzhou) Co. Ltd.Withdrawn
-
Beijing Tsinghua Chang Gung HospitalUnknownHepatocellular Carcinoma | Portal Vein Tumor ThrombosisChina
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Tianjin Medical University Cancer Institute and...RecruitingHepatocellular CarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingSolid Malignancies or LymphomasAustralia
-
The First Affiliated Hospital of Soochow UniversityInnovent Biologics (Suzhou) Co. Ltd.CompletedRelapsed/Refractory Multiple MyelomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedHypercholesterolemiaChina
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingHealthy Participants | Atopic Dermatitis PatientsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
PfizerWithdrawn
-
Shandong Cancer Hospital and InstituteNot yet recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Mian XIRecruitingHepatocellular CarcinomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced Solid TumorChina
-
Chunrui LiInnovent Biologics (Suzhou) Co. Ltd.RecruitingRelapsed/Refractory Multiple MyelomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedHomozygous Familial HypercholesterolemiaChina
-
Sichuan Cancer Hospital and Research InstituteInnovent Biologics, Inc.UnknownNeoplasms | Respiratory Tract Diseases | Lung Diseases | Thoracic Neoplasms | Non-small-cell Lung Cancer
-
Taizhou HospitalUnknown
-
Fujian Haixi Pharmaceuticals Co., Ltd.Recruiting
-
Innovent Biologics (Suzhou) Co. Ltd.RecruitingSolid Tumors or LymphomaChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedAdvanced MalignanciesChina
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedHealthy Male SubjectsChina
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingLocally Advanced Unresectable or Metastatic Solid TumorsAustralia
-
The First Affiliated Hospital of Zhengzhou UniversityNot yet recruitingEsophageal Squamous Cell Carcinoma (ESCC) | PD-1 InhibitorsChina
-
Peking Union Medical College HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.; Xinda Biopharmaceutical GroupNot yet recruitingCarcinoma, Non-Small-Cell Lung
-
Innovent Biologics (Suzhou) Co. Ltd.CompletedCancer, Solid TumorChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Undifferentiated Pleomorphic Sarcoma | Recurrent Undifferentiated Pleomorphic Sarcoma | Locally Advanced Undifferentiated Pleomorphic Sarcoma | Unresectable Undifferentiated Pleomorphic SarcomaUnited States
-
Wuhan Union Hospital, ChinaRecruitingHepatocellular CarcinomaChina